Cargando...
Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
The phase 2 placebo‐controlled, double‐blind PLUTO trial characterized the pharmacokinetics of belimumab plus standard systemic lupus erythematosus (SLE) therapy in patients with childhood‐onset SLE (cSLE) and demonstrated similar efficacy and safety to that in adult SLE. Patients with active cSLE a...
Gardado en:
| Publicado en: | Clin Pharmacol Drug Dev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246766/ https://ncbi.nlm.nih.gov/pubmed/33245847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.889 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|